Search for: "Eli Lilly And Company"
Results 21 - 40
of 1,165
Sorted by Relevance
|
Sort by Date
31 Jan 2008, 3:46 am
The New York Times is reporting that drug maker Eli Lilly is in settlement talks with the federal government regarding the company's marketing of the antipsychotic drug Zyprexa. [read post]
28 Feb 2013, 7:46 am
Indianapolis, IN - Eli Lilly and Company of Indianapolis, Indiana filed an additional patent infringement suit in the Southern District of Indiana alleging that Accord Healthcare, Inc., USA of Durham, North Carolina will infringe U.S. [read post]
6 Jan 2007, 3:22 pm
In 2005, Eli Lilly & Co., settled another 8,000 lawsuits against it for $700 million after Zyprexa's risks were exposed to the public. [read post]
6 Jan 2014, 6:15 am
(That's who challenged Eli Lilly's patents.) [read post]
6 Feb 2020, 12:43 pm
Indianapolis, Indiana – Attorneys for Plaintiff, Eli Lilly and Company (“Lilly”) of Indianapolis, Indiana, filed suit in the Southern District of Indiana seeking a declaratory judgment that Lilly did not misappropriate any trade secrets of Defendant, SensorRx, Inc. [read post]
24 Jul 2014, 9:06 am
The Wall Street Journal notes in an article Eli Lilly Profit Falls 39% on Patent Expirations The company said that patent expiration of the two treatments caused a 17% decline in volume during the quarter. [read post]
23 May 2019, 1:34 pm
Judges in the Indiana Court of Appeals issued their Opinion in the case of Neptune Generics, LLC, and Fresenius Kabi USA, LLC (collectively “Petitioners”) versus Eli Lilly and Company. [read post]
23 Apr 2012, 1:46 pm
Here are a few we have blogged about: Eli Lilly and Company Sues Accord Healthcare for Patent Infringement of Lung Cancer Drug ALIMTA Eli Lilly Company Sues APP Pharmaceuticals LLC for Patent Infringement of Chemotherapy Drug Lilly Wins Patent Infringement Suit Regarding Chemotherapy Drug [read post]
10 Apr 2019, 8:00 am
Eli Lilly claims that it is the assignee of the ‘209 patent, a method patent which was upheld as valid by the Federal Circuit in, Eli Lilly and Company v. [read post]
16 Mar 2018, 12:00 am
Eli Lilly argued the proposal may be excluded from the company’s proxy materials under Rule 14a-8(i)(10). [read post]
29 Nov 2008, 6:16 pm
Read: Jeffrey Young, The Hill, 9-24-08, Eli Lilly to disclose financial ties to doctors [read post]
29 Apr 2009, 12:44 pm
Many of the lawsuits filed against Eli Lilly and Co. contend the company has misled patients and physicians about Zyprexa’s potential side effects. [read post]
24 Jan 2011, 12:31 pm
On January 20, 2011, Eli Lilly and Company of Indianapolis, Indiana (“Lilly”) filed a complaint requesting that the ITC commence an investigation pursuant to Section 337. [read post]
8 Sep 2014, 5:00 am
We saw in our coverage of Eli Lilly’s patent applications a number of recently developed medications for the management of conditions like diabetes and inflammatory diseases, but the company is also focused on developing solutions to medical problems which are much more devastating. [read post]
13 Oct 2013, 12:21 pm
Not all of Eli Lilly and Company’s developments are strictly related to human health. [read post]
7 Dec 2017, 9:34 pm
Seeking approval to market generic versions of Eli Lilly's Axiron® testosterone applicator, Defendants Perrigo Company and Perrigo Israel Pharmaceuticals Ltd., Actavis Laboratories UT, Inc., FKA Watson Laboratories Inc., Lupin Pharmaceuticals, Inc. and Lupin Ltd., and Amneal Pharmaceuticals LLC filed... [read post]
13 Sep 2013, 6:55 am
Eli Lilly argues that the Canadian courts are creating too high of a standard for companies to prove the “usefulness” of their products when their patents are challenged by other firms seeking to produce their own versions of drugs. [read post]
8 Nov 2011, 10:33 am
His family alleged the company hid the drug’s diabetes risks to protect sales.Source: http://www.businessweek.com/news/2011-11-07/lilly-not-responsible-for-zyprexa-user-s-death-jury-finds.html [read post]
10 Oct 2017, 7:30 am
On Thursday, October 5th, a final written decision issued by the Patent Trial and Appeal Board (PTAB) upheld a series of 22 claims from a patent owned by Indianapolis, IN-based drugmaker Eli Lilly & Company (NYSE:LLY). [read post]
15 Oct 2018, 1:48 pm
The two companies signed a confidentiality agreement on November 21, 2012. [read post]